QSAR quantitative structure-activity cross-validation

Quantitative structure-activity/pharmacokinetic relationships (QSAR/ QSPKR) for a series of synthesized DHPs and pyridines as Pgp (type I (100) II (101)) inhibitors was generated by 3D molecular modelling using SYBYL and KowWin programs. A multivariate statistical technique, partial least square (PLS) regression, was applied to derive a QSAR model for Pgp inhibition and QSPKR models. Cross-validation using the leave-one-out method was performed to evaluate the predictive performance of models. For Pgp reversal, the model obtained by PLS could account for most of the variation in Pgp inhibition (R2 = 0.76) with fair predictive performance (Q2 = 0.62). Nine structurally related 1,4-DHPs drugs were used for QSPKR analysis. The models could explain the majority of the variation in clearance (R2 = 0.90), and cross-validation confirmed the prediction ability (Q2 = 0.69) [ 129]. 

In summary, the support vector machine (SVM) and partial least square (PLS) methods were used to develop quantitative structure activity relationship (QSAR) models to predict the inhibitory activity of nonpeptide HIV-1 protease inhibitors. Cenetic algorithm (CA) was employed to select variables that lead to the best-fitted models. A comparison between the obtained results using SVM with those of PLS revealed that the SVM model is much better than that of PLS. The root mean square errors of the training set and the test set for SVM model were calculated to be 0.2027, 0.2751, and the coefficients of determination (R2) are 0.9800, 0.9355 respectively. Furthermore, the obtained statistical parameter of leave-one-out cross-validation test (Q ) on SVM model was 0.9672, which proves the reliability of this model. Omar Deeb is thankful for Al-Quds University for financial support. 

---